Recent Quotes (30 days)

You have no recent quotes
chg | %

Ceapro Inc.  

(Public, CVE:CZO)   Watch this stock  
Find more results for CZO
0.245
-0.005 (-2.00%)
Delayed:   10:10AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.25 - 0.25
52 week 0.17 - 0.75
Open 0.25
Vol / Avg. 5,000.00/37,091.00
Mkt cap 15.17M
P/E 12.39
Div/yield     -
EPS 0.02
Shares 61.93M
Beta 1.93
Inst. own     -
Nov 12, 2015
Q3 2015 Ceapro Inc Earnings Release (Estimated) Add to calendar
Sep 10, 2015
Ceapro Inc at Rodman & Renshaw Global Investment Conference - 4:15PM EDT - Add to calendar
Aug 26, 2015
Q2 2015 Ceapro Inc Earnings Release
  

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -11.31% 17.93%
Operating margin -13.16% 22.49%
EBITD margin - 27.20%
Return on average assets -9.71% 24.94%
Return on average equity -35.29% 136.43%
Employees 12 -
CDP Score - -

Address

7824 51 Ave NW
EDMONTON, AB T6E 6W2
Canada
+1-780-4214555 (Phone)
+1-780-4211320 (Fax)

Website links

Description

Ceapro Inc. is a Canada-based growth-stage biotechnology company. The Company's primary business activities relate to the marketing and development of health and wellness products and technology relating to plant extracts. It develops and commercializes natural products for personal care, cosmetic, human and animal health industries. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides and lupin peptides, and Veterinary therapeutic products, including an oat shampoo, an ear cleanser and a dermal complex/conditioner, which are manufactured and marketed to veterinarians in Japan and Asia. Its wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Veterinary Products Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I.) Inc. and Ceapro USA Inc.

Officers and directors

Gilles R. Gagnon Chief Executive Officer, Director
Age: 61
Stacy Prefontaine Chief Financial Officer, Corporate Secretary
Glenn R. Rourke Independent Chairman of the Board
Ulrich Kosciessa Director
William W. Li M.D. Director
Age: 50
Donald J. Oborowsky Independent Director
John Zupancic Independent Director